- Gullestad L, Iversen M, Mortensen SA, Eiskjaer H, Riise GC, Mared L, Bjørtuft O, Ekmehag B, Jansson K, Simonsen S, Gude E, Rundqvist B, Fagertun HE, Solbu D, Bergh CH. Everolimus with reduced calcineurin inhibitor in thoracic transplant recipients with renal dysfunction: a multicenter, randomized trial. Transplantation 2010;89:864-72.
- Ueland T, Dahl CP, Kjekshus J, Hulthe J, Bohm M, Mach F, Gullestad L et al. Osteoprotegerin predicts progression of chronic heart failure: results from CORONA. Circulation: Heart Failure 2011;4:145-152.
- Gullestad L. Ueland T. Kjekshus J. Nymo SH. Hulthe J. Muntendam P. McMurray JJ. Wikstrand J. Aukrust P. The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA). American Heart Journal. 164(6):878-83, 2012.
- Gullestad L. Ueland T. Kjekshus J. Nymo SH. Hulthe J. Muntendam P. Adourian A. Bohm M. van Veldhuisen DJ. Komajda M. Cleland JG. Wikstrand J. McMurray JJ. Aukrust P. CORONA Study Group. Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA). European Heart Journal. 33(18):2290-6, 2012 Sep.
- Nytrøen K, Rustad LA, Hallén J, Fiane AE, Rolid K, Holm I, . Gullestad L. High intensity interval training improves maximum oxygen uptake and muscular exercise capacity in heart transplant recipients. Am J Transplant 2012;12:3134-3142.
- Gullestad L, Orn S, Dickstein K, Eek C, Edvardsen T, Aakhus S, Askevold ET, Michelsen A, Bendz B, Skårdal R, Smith HJ, Yndestad A, Ueland T, Aukrust P. Intravenous immunoglobulin does not reduce left ventricular remodeling in patients with myocardial dysfunction during hospitalization after acute myocardial infarction. Int J Cardiol. 2013 Sep 20;168(1):212-8.
- Andreassen AK, Andersson B , Gustafsson F, Eiskjær H, Rådegran G Gullestad L et al. Everolimus Intitation and Early calcineurin inhibitor withdrawal in Heart Transplant Recepients: A randomized trial. Am J Transplantation. 2014;14:1828.
- Broch K, Askevold ET, Gjertsen E, Ueland T, Yndestad A, Godang K, Stueflotten W, Andreassen J, Svendsmark R, Smith HJ, Aakhus S, Aukrust P, Gullestad L. The Effect of Rosuvastatin on Inflammation, Matrix Turnover and Left Ventricular Remodeling in Dilated Cardiomyopathy: A Randomized, Controlled Trial. PLOS one, 2014;9:e89732.
- Broch K, Urheim S, Lønnebakken MT, Stueflotten W, Massey R, Fosså K, Hopp E, Aakhus S, Gullestad L. Sustained release metoprolol for aortic regurgitation: a double blind, randomised, controlled trial of efficacy and safety. Heart 2015;102:191.
- Kleveland O, Kunszt G, Bratlie M, Ueland T, Broch K, Holte E, Michelsen AE, Bendz B, Amundsen BH, Espevik T, Aakhus S, Damås JK, Aukrust P, Wiseth R, Gullestad L. Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial. Eur Heart J. 2016 Aug 7;37(30):2406-13. doi:10.1093/eurheartj/ehw171. PubMed PMID: 27161611.
Publikasjoner
Her finner du en oversikt over forskergruppens utvalgte publikasjoner.
Publisert 13. aug. 2018 11:03
- Sist endret 13. aug. 2018 11:11